Ceremorphic Adds Industry Veterans in Life Sciences and Semiconductors to its Board of Directors

Ceremorphic today announced the addition of two key industry experts on its board of directors to strengthen its position and speed product deployments in both the datacenter and life sciences markets.

Ceremorphic, a fabless silicon and system development company, today announced the addition of two key industry experts on its board of directors to strengthen its position and speed product deployments in both the datacenter and life sciences markets. New appointments include Suresh Katta, a successful entrepreneur and founder and CEO of Saama Technologies, as well as Camillo Martino, a semiconductor veteran who has been CEO and C-suite executive in a number of high growth technology companies.

“Ceremorphic is on track to deliver century defining innovations in energy-efficient AI supercomputing, and the addition of Suresh and Camillo will be instrumental in driving our next wave of expansion,” said Dr. Venkat Mattela, Founder and CEO of Ceremorphic. “Suresh brings extensive experience in Lifesciences to propel our Biocompute Datacenter system architecture technology into the AI drug discovery field. Likewise, Camillo has vast experience in the semiconductor industry with a proven history of growing businesses and developing longer term strategies, which will be key as Ceremorphic continues to solve today’s most challenging supercomputing problems.”

Exit mobile version